Brought to you by 
Flagship Ventures backs Moderna Therapeutics with $40mm in early-stage financing
19 Dec 2012
Executive Summary
Coming out of stealth mode, Moderna Therapeutics Inc. (endogenous therapeutic proteins) has raised over $40mm in early-stage venture financing led by Flagship Ventures and undisclosed wealthy individual backers.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com